Author Archives: Robert S. Danziger

Perspective: Is the Bayh-Dole Act Stifling Biomedical Innovation?


This article is in Infrastructure for a Stormy Future, Winter 2018


The productivity of biomedical research has fallen dramatically during the past three decades. For example, Nicholas Bloom and colleagues, in a 2017 National Bureau of Economic Research working paper, found that productivity in cancer research (measured as the ratio between years of life saved per one hundred thousand people and the number of publications reporting […]